Effect of Two-Day Atorvastatin Pretreatment on the Incidence of Periprocedural Myocardial Infarction Following Elective Percutaneous Coronary Intervention: A Single-Center, Prospective, and Randomized StudyJosef Veselka, David Tesař, David Zemánek et al.|The American Journal of Cardiology|2009Cited by 41
Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise testJosef Veselka, T Honĕk, Šárka Procházková et al.|Coronary Artery Disease|2002Cited by 38
Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary interventionJosef Veselka, Kevin A. Bybee, Šárka Procházková et al.|Heart and Vessels|2006Cited by 28
Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized studyDavid Zemánek, Josef Veselka, Marian Branny et al.|International Journal of Cardiology|2013Cited by 19
The anomalous origin of the left coronary artery from the right aortic sinus: is the coronary angiography still a ‘gold standard’?David Zemánek, David Tesař, Josef Veselka et al.|International journal of cardiac imaging|2005Cited by 18